Notice of Results

Cambridge Antibody Tech Group PLC 18 May 2006 Page 1 of 1 FOR IMMEDIATE RELEASE Thursday 18th May 2006 For further information contact: Cambridge Antibody Technology Hogarth (Europe) Tel: +44 (0) 1223 471 471 Tel: +44 (0) 20 7357 9477 Peter Chambre, Chief Executive Officer Melanie Toyne-Sewell John Aston, Chief Financial Officer Andrew Jaques Rowena Gardner, Director of Corporate Communications BMC Communications/The Trout Group(USA) Tel: 001 212 477 9007 Brad Miles, ext 17 (media) Brandon Lewis, ext 15 (investors) NOTIFICATION OF RESULTS Cambridge, UK... Cambridge Antibody Technology Group plc ("CAT") (LSE: CAT; NASDAQ: CATG) will be announcing its interim results at 7am BST on Monday 22 May 2006. Following the recent announcement of the recommended cash offer by AstraZeneca International plc for CAT, the Company will be issuing a shortened interims statement reflecting the Company's present position, but will not be holding a group meeting or conference call for analysts on the day. - ENDS - This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings